Daily Med News

Implications of expansion of Alzheimer’s biomarker testing for patients, families and policy

Written by David Miller

Advances in research have identified biomarker tests that make it possible to detect signs of neurodegenerative conditions such as Alzheimer's disease years before symptoms appear, creating new opportunities for earlier intervention—and new questions for clinicians, patients and families.

Source: Medical Xpress

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]